DekaBank Deutsche Girozentrale’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Hold |
40,745
| – | – | ﹤0.01% | 741 |
|
|
2025
Q1 | $2.81M | Hold |
40,745
| – | – | 0.01% | 672 |
|
|
2024
Q4 | $2.09M | Hold |
40,745
| – | – | ﹤0.01% | 737 |
|
|
2024
Q3 | $2.18M | Hold |
40,745
| – | – | ﹤0.01% | 740 |
|
|
2024
Q2 | $2.26M | Hold |
40,745
| – | – | ﹤0.01% | 739 |
|
|
2024
Q1 | $2.81M | Buy |
40,745
+745
| +2% | +$51.3K | 0.01% | 692 |
|
|
2023
Q4 | $2.57M | Hold |
40,000
| – | – | 0.01% | 726 |
|
|
2023
Q3 | $1.83M | Hold |
40,000
| – | – | ﹤0.01% | 762 |
|
|
2023
Q2 | $2.28M | Buy |
40,000
+20,000
| +100% | +$1.14M | 0.01% | 721 |
|
|
2023
Q1 | $883K | Sell |
20,000
-843
| -4% | -$37.2K | ﹤0.01% | 899 |
|
|
2022
Q4 | $841K | Buy |
20,843
+843
| +4% | +$34K | ﹤0.01% | 923 |
|
|
2022
Q3 | $1.3M | Sell |
20,000
-25,660
| -56% | -$1.67M | ﹤0.01% | 808 |
|
|
2022
Q2 | $2.88M | Hold |
45,660
| – | – | 0.01% | 646 |
|
|
2022
Q1 | $2.93M | Buy |
45,660
+10,500
| +30% | +$673K | 0.01% | 676 |
|
|
2021
Q4 | $2.7M | Sell |
35,160
-15,650
| -31% | -$1.2M | 0.01% | 708 |
|
|
2021
Q3 | $5.6M | Buy |
50,810
+6,000
| +13% | +$661K | 0.02% | 509 |
|
|
2021
Q2 | $6.74M | Buy |
44,810
+8,500
| +23% | +$1.28M | 0.02% | 455 |
|
|
2021
Q1 | $4.18M | Buy |
36,310
+20,000
| +123% | +$2.3M | 0.01% | 533 |
|
|
2020
Q4 | $2.57M | Buy |
16,310
+2,860
| +21% | +$451K | 0.01% | 608 |
|
|
2020
Q3 | $1.14M | Buy |
+13,450
| New | +$1.14M | 0.01% | 723 |
|